NEW YORK — Kyowa Hakko Bio, Co., Ltd. and Kyowa Hakko USA, Inc., a subsidiary of Kirin Holdings Co., has opened its expanded citicoline manufacturing facility at its Kyowa Hakko Bio Yamaguchi Production Center in Hofu City, Yamaguchi Prefecture, Japan.

With the expanded facility, the Kirin Group is planning to integrate citicoline into upcoming product development initiatives, the company said. Kyowa Hakko Bio manufactures Cognizin, a citicoline brand, through a fermentation process for health food and pharmaceutical manufacturers. Cognizin is a brain-health nutrient, which may support mental energy, focus, attention and recall and may be added to food supplements and food for special medical uses, according to the company.

Kyowa Hakko Bio is a Japan-based biotechnology and fermentation company and offers ingredients such as amino acids, nucleic acid-related compounds, vitamins, organic acids and oligosaccharides and dipeptides for the pharmaceutical, nutrition and health care industries.